Dr. Michael J. Kennelly, MD

Dr. Kennelly practices at Atrium Health Carolinas Rehabilitation in Charlotte, North Carolina, part of Advocate Health.

Dr. Kennelly's NPI, 1720021637, was assigned on June 14, 2006. Dr. Kennelly graduated from University of Cincinnati College of Medicine in 1989. Dr. Kennelly holds North Carolina license 9500634.

Dr. Kennelly's primary practice is Atrium Health Carolinas Rehabilitation, at 1100 Blythe Boulevard, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-4370.

Dr. Kennelly's primary practice is Atrium Health Carolinas Rehabilitation in Charlotte, North Carolina, part of Advocate Health. Dr. Kennelly is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Atrium Health Levine Children's Gastroenterology. Dmand AI also links Dr. Kennelly to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kennelly practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kennelly's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kennelly is licensed in North Carolina.

CMS data shows 15,479 Medicare services from Dr. Kennelly across 29 procedure codes in 2024, for 632 Medicare patients. Medicare paid $226,817 for them.

CMS counts 632 Medicare patients who saw Dr. Kennelly in 2024. The largest group is 75 to 84, with 257 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kennelly's median patient age at 71, with 53% women.

In 2024, Dr. Kennelly wrote 867 Medicare Part D claims for 235 patients. 57% of them were for generic drugs. CMS names the drug for 791 of them, across 19 drugs with 11 or more claims each, at $291,677 in total drug cost. In 2023, CMS named 653 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kennelly for performance year 2024, reported through an alternative payment model (APM). CMS lists Dr. Kennelly as offering telehealth.

Dmand AI links 69 papers to Dr. Kennelly, published from 2009 to 2025. 2018 was the busiest year, with 7. The most frequent topics are Urinary Bladder, Overactive, Urinary Bladder, Neurogenic and Spinal Cord Injuries. Dr. Kennelly has published most often in Neurourol Urodyn. Dr. Kennelly's most frequent co-authors are David R. Staskin, MD, Kevin D. Benson, MD and Todd A. Linsenmeyer, MD.

Dmand AI links Dr. Kennelly to 5 clinical trials. 2 are still active or recruiting. Conditions studied include Nocturnal Enuresis, Urethral Stricture and Urinary Bladder, Neurogenic. Open Payments lists research payments to Dr. Kennelly that name 1 trial.

CMS Open Payments shows 2,372 general payments to Dr. Kennelly from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Allergan Inc. paid the most, $359,062. It also lists 4 research payments totaling $5,121 from 2017 to 2022, naming 1 clinical trial.

Dr. Kennelly graduated from University of Cincinnati College of Medicine in 1989.